Assyro AI

FDA Orange Book · active-ingredient family

Nedocromil sodium

Nedocromil sodium is approved as 3 brand and 1 generic application in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:ALOCRIL · NDA 021009

3

Brand (NDA)

1

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · aerosol, metered, solution, solution/drops

ProductApplicantApplicationTEApproved
ALOCRILRLDALLERGANNDA 021009Dec 08, 1999
TILADESANOFI AVENTIS USNDA 020750Oct 01, 1997
TILADEKING PHARMS LLCNDA 019660Dec 30, 1992

Generic (ANDA) products (1)

ProductApplicantApplicationTEApproved
NEDOCROMIL SODIUMEPIC PHARMA LLCANDA 090638Aug 22, 2012

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Nedocromil sodium — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.